Cardinal Health Rating Reiterated by Barclays (CAH)
Cardinal Health (NYSE:CAH)‘s stock had its “overweight” rating reaffirmed by investment analysts at Barclays in a note issued to investors on Tuesday. They currently have a $82.00 target price on the stock, up from their previous target price of $77.00. Barclays’ target price points to a potential upside of 16.68% from the company’s current price.
In other Cardinal Health news, CAO Stuart G. Laws unloaded 21,266 shares of Cardinal Health stock on the open market in a transaction that occurred on Thursday, July 24th. The stock was sold at an average price of $72.50, for a total transaction of $1,541,785.00. The transaction was disclosed in a filing with the SEC, which is available at this link.
Shares of Cardinal Health (NYSE:CAH) traded up 0.80% during mid-day trading on Tuesday, hitting $70.84. The stock had a trading volume of 1,430,108 shares. Cardinal Health has a 1-year low of $49.65 and a 1-year high of $74.40. The stock’s 50-day moving average is $70.29 and its 200-day moving average is $69.28. The company has a market cap of $24.100 billion and a price-to-earnings ratio of 70.28.
Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Monday, August 4th. The company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the previous year, the company posted $0.79 earnings per share. The company’s revenue for the quarter was down 9.9% on a year-over-year basis. Analysts expect that Cardinal Health will post $4.25 EPS for the current fiscal year.
A number of other firms have also recently commented on CAH. Analysts at Credit Suisse reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday. They now have a $80.00 price target on the stock, up previously from $76.00. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Cardinal Health in a research note on Tuesday. They now have a $74.00 price target on the stock. Finally, analysts at Leerink Swann raised their price target on shares of Cardinal Health from $78.00 to $84.00 in a research note on Tuesday. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $78.03.
Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.
Receive News & Ratings for Cardinal Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.